1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Patient characteristics, clot histology, and procedural parameters
No. or Median with Interquartile Range
Patients (No.)85
Male/female (No.)40/45 (47%/53%)
Age (median) (yr)73 (65–80)
POS (No.)
    ICA/carotid-T26 (30.6%)
    ACA2 (2.3%)
    MCA57 (67.1%)
IV rtPA bridging therapy (No.)58 (68%)
Maneuvers (No.)2 (1–4)
Procedure time for POS recanalization (min)37 (21–64)
TICI after POS recanalization (No.)
    11 (1%)
    2a27 (32%)
    2b21 (25%)
    336 (42%)
Occlusions due to PTF (n = 101)
    Proximal26 (26%)
    Intermediate50 (50%)
    Distal25 (25%)
Clot histology (fraction in %)
    RBC37 (27–48)
    F/P57 (47–67)
    WBC5 (4–7)